Cefiderocol: Clinical Trials

4 trials of Cefiderocol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Recruiting 3, Completed 1

Follow Cefiderocol: new trials by email Literature Review of Cefiderocol trials Research Report on Cefiderocol

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn Injuries
Cefiderocol - Drug Clearance After Severe Burn Injury
Phase 4RecruitingUniversity of Tennessee122026-02-162026-03-12
Optimising TREATment for Severe Gram-Negative Bacterial Infections
Colistin/Polymyxin B + Sulbactam, Colistin/Polymyxin B + Tigecycline/Eravacycline, Colistin/Polymyxin B + Meropenem - Bloodstream Infection, Ventilator Associated Bacterial Pneumonia
Phase 4RecruitingNational University of Singapore6002025-04-212025-06-04
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Cefiderocol, Ampicillin-sulbactam, Colistin - Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia
Phase 4RecruitingRambam Health Care Campus7342024-09-012025-08-01
Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis
Cefiderocol - Cystic Fibrosis, Pneumonia, Bacterial
Phase 4CompletedHartford Hospital102022-06-012024-12-16

Conditions studied

Burns (1)  ·  Cystic Fibrosis (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Pneumonia, Bacterial (1)  ·  Sepsis (1)

Sponsors

Hartford Hospital (1)  ·  National University of Singapore (1)  ·  Rambam Health Care Campus (1)  ·  University of Tennessee (1)

Countries

United States (2)  ·  Australia (1)  ·  China (1)  ·  Israel (1)  ·  Lebanon (1)  ·  Malaysia (1)  ·  Qatar (1)  ·  Saudi Arabia (1)  ·  Singapore (1)  ·  South Africa (1)  ·  Spain (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)  ·  United Arab Emirates (1)

Top investigators

Dafna Yahav (1)  ·  Joseph L Kuti, PharmD (1)  ·  Marco Falcone (1)  ·  Mical Paul (1)

Results publications

PMID 29456043